Relation of Plasma Lipoprotein Levels With Low-Grade Inflammation in White Men Without Clinical Evidence of Myocardial Ischemia

American Journal of Cardiology

Volumn 100, Issue 3, 2007, Pages 450-454

  Rivera, Juan J ^a   Nasir, Khurram ^b   Campbell, Catherine ^a   Carvalho, Jose A M ^c   Blumenthal, Roger S ^a   Santos, Raul D ^c,d  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; GENDER; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; INFLAMMATION; LEUKOCYTE; LEUKOCYTE COUNT; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 34447621247     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.03.044     Document Type: Article

References (25)

1. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
2. Weijenberg M.P., Feskens E.J., and Kromhout D. White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arterioscler Thromb Vasc Biol 16 (1996) 499-503
3. Gillum R.F., Ingram D.D., and Makuc D.M. White blood cell count, coronary heart disease, and death: the NHANES I epidemiologic follow-up study. Am Heart J 125 (1993) 855-863
4. De Labry L.O., Campion E.W., Glynn R.J., and Vokonas P.S. White blood cell count as a predictor of mortality; results over 18 years from the Normative Aging Study. J Clin Epidemiol 42 (1990) 153-157
5. Grimm R.H., Neaton J.D., and Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all cause mortality. JAMA 254 (1985) 1932-1937
6. Brown D., Giles W.H., and Croft J.B. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol 54 (2001) 316-322
7. Sabatine M.S., Morrow D.A., Cannon C.P., Murphy S.A., Demopoulos L.A., Dibattiste P.M., McCabe C.H., Braunwald E., and Gibson C.M. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 substudy. J Am Coll Cardiol 40 (2002) 1762-1768
8. Hokanson J.E., and Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3 (1996) 213-219
9. Onat A., Sari I., Yazici M., Can G., Hergenc G., and Avci G.S. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome. Int J Cardiol 108 (2006) 89-95
10. Farin H.M., Abbasi F., Kim S.H., Lamendola C., McLaughlin T., and Reaven G.M. The relationship between insulin resistance and dyslipidaemia in cigarette smokers. Diabetes Obes Metab 9 (2007) 65-69
11. National Heart, Lung, and Blood Institute, American Heart Association, Grundy S.M., Brewer Jr. H.B., Cleeman J.I., Smith Jr. S.C., and Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 24 suppl (2004) e13-e18
12. Lakka T.A., Laaksonen D.E., Lakka H.M., Mannikko N., Niskanen L.K., Rauramaa R., and Salonen J.T. Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome. Med Sci Sports Exerc 35 (2003) 1279-1286
13. Kostis J.B., Turkevich D., and Sharpe J. Association between leukocyte count and the presence and extent of coronary atherosclerosis as determined by coronary arteriography. Am J Cardiol 53 (1984) 997-999
14. Jeppesen J., Hein H.O., Suadicani P., and Gyntelberg F. Relation of high triglycerides-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease: an 8 year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vasc Biol 17 (1997) 1114-1120
15. Grundy S.M., and Vega G.L. Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Arch Intern Med 152 (1992) 28-34
16. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
17. De Backer G., Ambrosioni E., Borch-Johnsen K., Brotons C., Cifkova R., Dallongeville J., Ebrahim S., Faergeman D., Graham I., Mancia G., et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Atherosclerosis 173 (2004) 381-391
18. MRC/BHF Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. Eur Heart J 10 (1999) 725-741
19. Ridker P.M., Rifai N., Cook N.R., Bradwin G., and Buring J.E. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 294 (2005) 326-333
20. Criqui M.H., Heiss G., Cohn R., Cowan L.D., Suchindran C.M., Bangdiwala S., Kritchevsky S., Jacobs Jr. D.R., O'Grady H.K., and Davis C.E. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 328 (1993) 1220-1225
21. Stampfer M.J., Krauss R.M., Ma J., Blanche P.J., Holl L.G., Sacks F.M., and Hennekens C.H. A prospective study of triglyceride level, low density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 276 (1996) 882-888
22. Manninen V., Tenkanen L., Koskinen P., Huttunen J.K., Manttari M., Heinonen O.P., and Frick M.H. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Circulation 85 (1992) 37-45
23. Bainton D., Miller N.E., Bolton C.H., Yarnell J.W., Sweetnam P.M., Baker I.A., Lewis B., and Elwood P.C. Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischemic heart disease in British men: the Caerphilly and Speedwell collaborative heart studies. Br Heart J 68 (1992) 60-66
24. Burchfiel C.M., Laws A., Benfante R., Goldberg R.J., Hwang L.J., Chiu D., Rodriguez B.L., Curb J.D., and Sharp D.S. Combined effects of HDL cholesterol, triglyceride, and total cholesterol concentrations on 18-year risk of atherosclerotic disease. Circulation 92 (1995) 1430-1436
25. Assmann G., Schulte H., and von Eckardstein A. Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 77 (1996) 1179-1184